
Torrent Group on Monday, announced its entry into medical testing through a new arm, Torrent Diagnostics, as per news reports. The business begins with a national reference laboratory in Navi Mumbai, described by the company as the country’s largest.
This broadens its healthcare portfolio. The company has not shared details of the capital expenditure for the project.
Torrent has structured the business around a centralised reference laboratory model. The unit is expected to process specialised and high-end tests for hospitals, clinicians and smaller laboratories that outsource complex diagnostics.
The company said the model is intended to maintain standard validation and quality processes. Varun Mehta, Director at Torrent Group, said the business has been built with a focus on scientific processes and long-term consistency.
The Navi Mumbai laboratory is spread over 100,000 square feet. It offers more than 3,500 tests across 15 diagnostic disciplines. These include routine pathology, preventive health checks, molecular diagnostics, genomics, microbiology and transplant-related testing.
The facility is equipped with Next-Generation Sequencing (NGS) platforms, MALDI-TOF systems and BSL-3 laboratories. It also houses a Transmission Electron Microscope (TEM), which the company said is the first installed in a standalone diagnostics laboratory in western India.
India’s diagnostics industry is estimated at around ₹55,000 crore and remains fragmented. Organised players account for nearly 15% of the market, with their share expected to rise over time. Diagnostics are estimated to influence over 70% of clinical decisions.
Pharmaceutical companies have gradually expanded into this space. In 2021, Lupin set up Lupin Diagnostics and established a reference laboratory in Navi Mumbai.
Read More: 22 Bidders, Including Jindal Power and Vedanta, Submit Offers for Gupta Power Amid Insolvency Proceedings!
With the launch of Torrent Diagnostics, the group has added laboratory services to its healthcare portfolio, beginning with a centralised reference facility in Navi Mumbai.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 24, 2026, 1:37 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
